Topamax is a medication that has been shown to significantly improve symptoms for individuals with epilepsy. Unfortunately, recent research has shown that mothers who take this medication while pregnant are at a significantly higher risk of having a child with a birth defect than those who were on other anticonvulsant medications or those not taking medications at all. These birth defects can have a remarkably negative impact on the lives of both the child and their parents.
Until recently, the impact of Topamax on pregnant women and their children was not widely known. However, the FDA has now placed Topamax in Category D for pregnant users, indicating that these effects are now acknowledged and that the use of Topamax may be inadvisable for pregnant women. For women who have already suffered the birth of a child with a birth defect, however, this stands as little consolation for the pain and suffering they’ve undergone.
Birth Defects Linked to Topamax
The use of Topamax has been primarily associated with the development of three different birth defects, which include the following:
- Cleft Lip
- Cleft Palate
Without treatment, some of these conditions have the potential to pose life-threatening health challenges to those who suffer them. Unfortunately, the treatment options available for families with children born with any of these conditions are often prohibitively expensive, placing families in the difficult position of choosing between their own financial stability and their children’s health. No family should have to cope with this type of terrible decision.
Fortunately, those whose children developed a birth defect as a result of the drug Topamax may be entitled to seek compensation for their losses through a Topamax lawsuit. Because its medication was more dangerous for pregnant women than initially acknowledged, the makers of Topamax may be held financially liable for the damages they may have caused.
Dealing with type-2 diabetes is hard enough; imagine the pain of knowing you have developed bladder cancer because of the medications you have taken to treat your type-2 diabetes. Unfortunately, studies have discovered that taking the medication Actos to treat type-2 diabetes has increased patients’ chances of developing bladder cancer, especially if they have taken the medication for more than a year.
Actos, with the generic name pioglitazone, is manufactured by Takeda Pharmaceuticals specifically for treatment of type-2 diabetes. Although it excelled against its competitions in treating the ailment, studies have found out that the company failed to warn patients and doctors of its adverse effects, particularly its link to bladder cancer. Because of this, patients who have developed bladder cancer have filed claims with their Actos lawyers to get proper compensation for all their pain and suffering.
If you or any of your loved ones have type-2 diabetes and have taken Actos, there are ways in helping you determine if you have bladder cancer or not. The most obvious and common symptom is having blood in the urine. Pain during urination is also a tell-tale sign, as well as frequent urination. If you have trouble urinating, it can also be a sign of bladder cancer, while fatigue, abdominal pain and lower back pain can also be something to consider. Even so, patients taking Actos should not wait for these symptoms to be present or felt; it would be better to just go to their doctor and get tested.
Although bladder cancer can be treatable, it is still a heavy physical and psychological burden to bear; dealing with type-2 diabetes along with bladder cancer can cause even greater physical and emotional pain, all while exhausting your finances. Making the manufacturer responsible for their negligence and disregard of their patients’ health is one way to ensure that these things are prevented. An Actos lawyer can considerably increase your chances of getting the compensation you deserve.